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DObjective: Asymmetric septal hypertrophy frequently coexists with severe aortic stenosis and can be unmasked
after successful aortic valve replacement (AVR), jeopardizing the clinical and echocardiographic results. The
aim of our study was to investigate, at 5 years postoperatively, the effectiveness of myectomy associated with
AVR on left ventricular (LV) mass regression and LV diastolic function.
Methods: From 1997 and 2004, 86 patients with a diagnosis of severe aortic stenosis and asymmetric septal
hypertrophy consecutively underwent AVR (group A) or AVR and concomitant myectomy (group B). To assess
the improvement in LV mass and LV diastolic function, we studied the 52 survivors (23 in group A and 29 in
group B) who had the same prosthesis type (beleaflet mechanical), the same size (21 mm), and the same
follow-up length.
Results: In group A, the LV mass index regressed from 119.2  22.0 to 113.8  21.8, and in group B, it re-
gressed from 121.6  20.8 to 112.7  20.0 (P<.0005). In group A, the E/E0 ratio improved from 15.3  3.0
to 11.8  3.0, and in group B, it improved from 16.2  3.2 to 12.1  3.3 (P ¼ .02).
Conclusions: Surgeons should inspect the LVoutflow tract at AVR. Concomitant myectomy at AVR is a safe and
effective procedure that improves LV mass regression and LV diastolic function. (J Thorac Cardiovasc Surg
2013;145:171-5)In aortic stenosis (AS), left ventricular (LV) hypertrophy is
an adaptive process that compensates for ventricle pressure
overload. This process is accompanied by a remodeling of
the left ventricle that involves the muscular and nonmuscu-
lar compartments of the ventricle with muscle hypertrophy
and abnormalities of the collagen network.1 Usually this de-
gree or type of LV remodeling is uniform and symmetric;
however, sometimes an area of the left ventricle shows
a nonuniform pattern of hypertrophy in which 1 portion
of the ventricle—usually the septum—shows a greater de-
gree of thickening than other areas.2 This type of hypertro-
phy in the setting of valvular AS is not uncommon and can
be easily overlooked at aortic valve replacement (AVR).
After AVR, the persistence of this degree of asymmetric
LV hypertrophy with an intraventricular gradient can lead to
less than optimal early and late postoperative results, in-
cluding a lack of abolition of gradient into the LV outflow
tract, a lack of regression of the LV mass (LVM), diastolic
dysfunction and, sometimes, persistence of symptoms.3,4e Division of Cardiac Surgery, University Federico II Medical School, Na-
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The Journal of Thoracic and CaIn this situation, the operative approach is not uniform
and not many studies that can help in the decision-making
process are available. Most surgeons perform only AVR,
on the assumption that, by reducing the LV afterload with
the valve replacement, it induces a trend toward the normal-
ization of LV hemodynamics. However, others have recom-
mended a more liberal use of septal myectomy at AVR.5
Doppler tissue imaging (DTI) is an ultrasound modality
that, through measurements of the systolic and diastolic ve-
locities within the myocardium and at the corners of the mi-
tral annulus, reflects the shortening and lengthening of the
myocardial fibers along a longitudinal plane, thus allowing
a precise estimate of diastolic function.6
To precisely assess the value and safety of associated sep-
tal myectomy at AVR and the improvements in LVM and di-
astolic function, we retrospectively compared 2 groups of
patients with the same preoperative asymmetric septal
thickness who underwent surgery by the same surgical
group in 2 different periods: 1 group underwent only AVR
and 1 group underwent septal myectomy in association
with AVR.
METHODS
The retrospective nature of the study induced us to adopt strict criteria
for patient enrollment to achieve meaningful results. From January 1997 to
December 2004, 591 consecutive patients with a diagnosis of severe AS un-
derwent AVR at our institution. Of these patients, 86 (14%) had asymmet-
ric septal hypertrophy. From January 2000 onward, we added septal
myectomy to AVR for these patients. Thus, 34 patients underwent AVR
only (group A, from January 1997 to December 1999) and 52 patients un-
derwent AVR plus septal myectomy (group B, from January 2000 tordiovascular Surgery c Volume 145, Number 1 171
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DDecember 2004). Because the valve annulus and the size and type of the
prosthesis implanted can influence the behavior of the left ventricle at
late follow-up,7 from the 86 patients, we identified those patients with
the same prosthesis type and size and same follow-up length. We selected
the St Jude and Carbomedics mechanical valves, which are the preferred
mechanical valves at our center,8 and we selected a prosthesis size of 21
mm, which is the size we mostly use for severe AS. Therefore, we com-
pared 23 (67.6%) of 34 patients who underwent AVR (group A) and 29
(55.7%) of 52 patients who underwent associated myectomy at AVR
(group B), who had the same follow-up length of 5 years.
For the purposes of the present study, asymmetric septal hypertrophy
was echocardiographically defined as a disproportional thickness of the in-
terventricular septum compared with the LV posterior wall. The septal/pos-
terior wall thickness ratio was set at 1.3 or greater2,9 (range, 13 to 17 mm).
Severe AS was defined as a mean aortic gradient greater than 40 mm Hg,
aortic valve area less than 1.0 cm2, and a jet velocity greater than 4 m/s.10
We carefully excluded patients with the diagnosis of hypertrophic car-
diomyopathy or dynamic outflow tract obstruction with systolic anterior
motion of the mitral valve and those who had septal hypertrophy in the set-
ting of less than severe AS. Finally, to avoid any bias owing to the role of
the mitral valve on the outflow tract of the left ventricle, we also excluded
patients undergoing concomitant procedures on the mitral valve.
Patients with concomitant coronary artery bypass grafting were in-
cluded, because at our center, they constitute a large fraction of those
undergoing AVR.8
The institutional research ethics committee approved the present study,
and all patients provided written informed consent.
Preoperative and Postoperative Evaluations
The diagnosis of severe AS was confirmed preoperatively by transtho-
racic echocardiography within 2 weeks of surgery. All patients also under-
went an echocardiographic study (transesophageal) intraoperatively and
before hospital discharge (transthoracic). At 5 years of follow-up, echocar-
diography was performed by echocardiographers who were unaware of the
treatment received. Conventional Doppler echocardiographic and DTI data
were obtained from all surviving patients. Two-dimensional and Doppler
echocardiographic studies were performed with a commercially available
echocardiography unit, equippedwith an imaging transducer having pulsed
wave and DTI capability. All Doppler echocardiographic examinations and
DTI recordings were measured during normal respiration. Standard para-
sternal, apical, subcostal, and suprasternal views were obtained. The LV di-
ameter and thickness weremeasured usingM-mode echocardiography. The
LVM was calculated using the Penn formula described by Devereux and
Reichek.11 The LVM was indexed by dividing the LVM (in grams) by
the body surface area. Continuous-wave, pulsed-wave, and color Doppler
studies were made to assess the peak transvalvular gradient, mean trans-
valvular gradient, and effective orifice area of the aortic valve, respectively.
The peak and mean gradients were calculated using the modified Bernoulli
equation. The effective orifice area was calculated using the simplified con-
tinuity equation and indexed by the body surface area. From the apical win-
dow, the pulsed Doppler sample volumewas placed at the mitral valve tips,
and 5 to 10 cardiac cycles were recorded. For DTI, the filter setting was
lowered, and the Nyquist limit was adjusted to a range of 15 to 20 cm/s.
Gain was minimized to allow for a clear tissue signal with minimal172 The Journal of Thoracic and Cardiovascular Surgbackground noise. The E0 wave was measured from the apical 4-chamber
view, with a 2- to 5-mm sample volume placed at the septal corner of the
mitral annulus. The measurements were recorded with simultaneous elec-
trocardiography at a sweep speed of 50 to 100 mm/s. The measurements
were made in 3 to 5 cardiac cycles and averaged.
Operative Technique
Throughout the study period, the surgical and myocardial protection
procedures did not change. In both groups, AVR was undertaken through
a median sternotomy, with standard cardiopulmonary bypass under mild
hypothermia (32C) and cold blood cardioplegia. After removal of the usu-
ally calcified aortic valves, the prostheses were implanted with interrupted
horizontal mattress sutures with pledgeted 2-0 nonabsorbable braided poly-
ester. In group B, after the removal of the aortic valve and before implant-
ing the prosthesis, concomitant septal myectomy was performed. The
myectomy included resection of septal muscle from the nadir of the right
aortic sinus to the commissure between the left and right cusps, just as in
septal myectomy for hypertrophic obstructive cardiomyopathy. Of course,
septal myectomy in these patients was limited compared with what we usu-
ally perform for true hypertrophic obstructive cardiomyopathy.
Postoperatively, patients received lifelong warfarin anticoagulation,
with an international normalized ratio target of 2.0 to 2.5.8
The patients were annually seen by a cardiac surgeon of our team. Miss-
ing information was completed with the patient’s physician and/or the
patient’s family.
Statistical Analysis
Statistical analyses were performed using the Statistical Package for So-
cial Sciences, version 13.01, for Windows (SPSS, Chicago, Ill). Data are
expressed as the mean value standard deviation for continuous variables
and as numbers and percentages for categorical variables. The preoperative
and postoperative measurements were compared using Student’s paired t
test. The chi-square test or Fisher’s exact test (for sparse data) was used
to compare the categorical variables and to assess statistical significance
between the 2 groups. The 5-year follow-up period for each patient was cal-
culated from the date of operation to the fifth year of follow-up contact with
a surgeon of our team.RESULTS
The clinical characteristics and preoperative echocardio-
graphic measurements of the 52 surviving patients (23 in
group A and 29 in group B) are listed in Tables 1 and 2,
respectively. The 2 groups were homogeneous regarding
the demographic, clinical, and echocardiographic data.
Specifically, no differences were found in preoperative
aortic valve area or the peak or mean gradients. Most
patients had a calcific stenosis of either a tricuspid or
bicuspid aortic valve. A total of 16 patients, 8 in each
group, underwent associated coronary artery bypass
grafting. No patient developed permanent atrioventricular
block or septal perforation. Transient postoperative atrial
fibrillation developed in 19 patients (36.5%) that had
reverted to sinus rhythm before hospital discharge.
No structural or functional prosthesis abnormality was
found in either group.LVM and Geometry
LV remodeling due to the severe AS was documented by
an increased LVM, LVM index, and interventricularery c January 2013
TABLE 1. Preoperative and operative data
Variable
Group A
(n ¼ 23)
Group B
(n ¼ 29)
P
value
Age (y) 61.9  7.9 62.5  8.1 .9
Women 14 (60.9) 17 (58.6) .8
Body surface area (m2) 1.76  0.13 1.73  0.12 .4
Etiology
Rheumatic 6 (26.1) 9 (31.0) .9
Bicuspid aorta 3 (13.0) 2 (6.9) .2
Degenerative 14 (60.9) 18 (62.1) .9
Hypertension 14 (60.9) 17 (58.6) .9
Myocardial revascularization 8 (34.8) 8 (27.6) .8
Chronic obstructive pulmonary
disease
1 (4.3) 1 (3.4) .7
Diabetes mellitus 4 (17.4) 6 (20.7) .5
Chronic renal insufficiency 2 (8.7) 4 (13.8) .4
Cerebrovascular accident 4 (17.4) 5 (17.2) .6
Peripheral vascular disease 1 (4.3) 2 (6.9) .6
Symptoms
Syncope 3 (13.0) 7 (24.1) .2
Angina 9 (39.1) 14 (48.3) .7
Dyspnea 13 (56.5) 13 (44.8) .5
Asymptomatic 5 (21.7) 6 (20.7) .8
NYHA class III-IV 12 (52.2) 15 (51.7) .8
CCS class III-IV 12 (52.2) 14 (48.3) .8
Aortic valve area (cm2) 0.74  0.06 0.76  0.04 .1
Peak gradient (mm) 84.2  17.1 87.1  16.3 .5
Mean gradient (mm) 61.2  17.6 66.9  16.6 .2
Cardiopulmonary bypass (min) 87.2  47.3 91.7  51.5 .7
Aortic crossclamp duration (min) 68.8  22.1 72.1  19.9 .7
Data presented as mean standard deviation or numbers, with percentages in paren-
theses. NYHA, New York Heart Association (functional classification); CCS, Cana-
dian Cardiovascular Society (classification).
TABLE 2. Changes in LV function
Variable
Group A
(n ¼ 23)
Group B
(n ¼ 29)
P
value
Interventricular septum
Preoperatively (mm) 15.4  1.0 15.6  1.0 .47
At 5-yr of follow-up (mm) 14.0  1.4 13.6  1.2 .27
Regression (mm) 1.5  0.9 2.0  0.8 .03
Percentage of regression 9.8  6.1 13.1  5.1 .03
Posterior wall
Preoperatively (mm) 12.8  1.0 12.7  1.3 .76
At 5-yr of follow-up (mm) 11.5  1.6 11.1  1.9 .42
Regression (mm) 1.3  1.2 1.5  1.4 .58
Percentage of regression 8.3  6.9 12.1  10.5 .14
LVM
Preoperatively (g) 207.6  30.1 208.3  28.9 .93
At 5-yr of follow-up (g) 198.3  30.5 193. 2  28.7 .56
Regression (g) 9.3  3.3 15.0  7.8 .002
Percentage of regression 4.6  1.8 7.3  3.7 .002
LVM index
Preoperatively (g/m2) 119.2  22.0 121.6  20.8 .68
At 5-yr of follow-up (g/m2) 113.8  21.8 112.7  20.0 .85
Regression (g/m2) 5.3  1.9 8.8  4.2 .0005
Percentage of regression 4.6  1.8 7.3  3.7 .002
E/E0 ratio
Preoperatively 15.3  3.0 16.2  3.2 .33
At 5-yr of follow-up 11.8  3.0 12.1  3.3 .73
Regression 3.5  0.7 4.1  1.1 .02
LV ejection fraction (%)
Preoperatively (%) 59.8  8.4 58.9  6.8 .67
At 5-yr of follow-up (%) 61.7  8.5 62.5  6.3 .69
Regression (%) 2.6  3.1 3.5  2.8 .27
Data presented as mean  standard deviation. LV, Left ventricular; LVM, LV mass.
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values decreased in groups A and B at 5 years of follow-
up (Table 2). Patients with added myectomy (group B)
had a more favorable reduction in the LVM, LVM index,
and interventricular septum thickness than the patients
with AVR alone (group A). The LVM decreased from
207.6  30.1 g to 198.3  30.5 g in group A and from
208.3  28.9 g to 193.2  28.7 g in group B, with a regres-
sion ratio of 4.6  1.8 and 7.3  3.7, respectively
(P ¼ .002).
The LVM index decreased from 119.2  22.0 g/m2 to
113.8  21.8 g/m2 in group A and from 121.6  20.8
g/m2 to 112.7 20.0 g/m2 in group B, with a regression ra-
tio of4.6  1.8 in group A and 7.3  3.7 in group B
(P ¼ .002; Table 2).
Diastolic Function
The E/E0 ratio measurement had decreased at 5 years
postoperatively in both groups, but group B patients had
a more pronounced improvement in diastolic function
than did group A patients. The E/E0 ratio decreased from
15.3  3.0 to 11.8  3.0 in group A and from 16.2  3.2The Journal of Thoracic and Cato 12.1  3.3 in group B, with a regression ratio of 3.5 
0.7 and 4.1  1.1, respectively (P ¼ .02; Table 2).DISCUSSION
The present study has shown that in patients with a hyper-
trophied septum, septal myectomy in association with AVR
improves the regression of the LVM and diastolic function
and does not increase the operative risk.
Asymmetric septal hypertrophy has been defined ana-
tomically as disproportionate thickening of the anterior
ventricular septum relative to the posterior LV free wall
(usually a septal/free wall ratio  1:3).2,9 From the
available autopsy and echocardiographic data, about 10%
of patients with hemodynamically significant AS show
asymmetric thickening of the septum, which can be easily
overlooked at AVR, resulting in a residual intraventricular
gradient after successful AVR.12,13
No precise surgical guidelines are available for such
cases.Most surgeons performonlyAVR for 3 very important
reasons. First, the patients are sent to them by the cardiolo-
gist with the diagnosis of AS. Second, they believe that by
reducing the LVafterload with the replacement of the valve,rdiovascular Surgery c Volume 145, Number 1 173
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any septal surgery to avoid complications, such as perma-
nent atrioventricular block and septal perforation. Other
surgeons perform AVR and septal myectomy but only in
case of dynamic obstruction with systolic anterior motion
of the mitral valve.9 Only a few recommend a more liberal
use of septal myectomy in conjunction with AVR.5
These different surgical approaches result, in part, be-
cause the coexistence of asymmetric septal hypertrophy in
patients with severe AS cannot always be precisely estab-
lished preoperatively. Pressure measurements alone and
ventriculography are not reliable indexes for detecting
the severity of the obstruction.3,5 Sometimes, even
transthoracic and transesophageal echocardiography can
fail to properly detect septal hypertrophy.12 Therefore, the
decision of whether to perform myectomy is made by the
operating surgeon based on direct inspection (visual and
manual) of the LVoutflow tract after excision of the native
aortic valve.
The rationale for performing myectomy at AVR is two-
fold: (1) to improve the long-term results; and (2) to elimi-
nate the possibility that, once the aortic gradient has been
relieved by AVR, a potential dynamic subaortic gradient
would be ‘‘unmasked.’’ The patient would have had opera-
tive relief of the fixed AS only to be confronted acutely with
unanticipated subaortic stenosis with potentially deleterious
clinical consequences in the early and late postoperative pe-
riod. In a series of 11 patients with pure severe AS and with-
out any anatomic signs of subvalvular obstruction, Bird and
colleagues14 found a large subvalvular gradient that wors-
ened after AVR, thus, nullifying the results of an uneventful
operation. Aurigemma and colleagues3 stressed that the he-
modynamic changes after AVR can exacerbate a preexisting
obstruction, with life-threatening consequences. Ayerbe
and associates15 suggested prophylactic myectomy during
AVR for patients with marked septal hypertrophy. More-
over, even in the absence of a postoperative gradient at
rest, some amount of gradient can develop under stress after
AVR and could affect the speed of LVM regression.4,16
In patients in whom myectomy was performed, we ob-
served a regression of the LVM. Tasca and colleagues,4 in
their retrospective analysis, found that the relative LV re-
gression was significantly greater in patients who had un-
dergone myectomy plus AVR than in patients who had
undergone only AVR. Kayalar and colleagues,12 in their
retrospective review of 47 patients who had undergone
myectomy at AVR, found similar results at 1 year
postoperatively.
In patients with AS, diastolic dysfunction is frequently
observed. In such patients, LV hypertrophy is associated
with alterations in LV relaxation, filling, and passive elastic
properties, finally resulting in elevated end-diastolic pres-
sures. Thus far, the E/A ratio has generally been used to
evaluate the LV diastolic dysfunction. However, several174 The Journal of Thoracic and Cardiovascular Surglimitations in using the E/A ratio to asses LV diastolic func-
tion correctly have been detected, and the E/A ratio is no
longer used to precisely assess LV diastolic function.17
The limitations of conventional mitral or pulmonary vein
flow parameters in estimating the filling pressures of the left
ventricle appear to have been partially overcome with the
introduction of DTI. The early diastolic mitral annular ve-
locity (E0) was found to be less load dependent than the con-
ventional mitral flow variables, and the mitral E/E0 ratio was
suggested as an estimate of LV filling pressures.18 More-
over, the LV long-axis function reflects the position of the
longitudinally oriented muscle fibers, adding precision to
the LV evaluation.19 In our study, in the patients in whom
myectomy was added to AVR, the E/E0 ratio showed better
diastolic normalization than that in patients who had under-
gone AVR alone.
Concomitant myectomy at AVR does not increase the
operative risk. We did not have any patients with septal per-
foration or complete atrioventricular block requiring a per-
manent pacemaker. Also, reports from other centers have
reported a negligible incidence of this complication.4,12Study Limitations
One limitation is that the diastolic function was not eval-
uated with invasive catheter measurements, which is the ref-
erence standard. However, this invasive method is not
suitable for widespread use and routine follow-up. The
echocardiographic measurement of mitral E/E0 ratio has
been reported to be a precise estimate of LV filling pressures
and allows routine noninvasive assessments.
Also, the mitral annular velocities can be significantly al-
tered in the presence of coronary artery disease. LVM re-
gression is a highly complex phenomenon involving
hemodynamic and nonhemodynamic factors, including ge-
netic and environmental ones.20,21
The small number of patients, the high degree of selectiv-
ity, the 2 different study periods with a different surgical
strategy can also be considered limitations of our study;
however, our inclusion criteria were strict, which may
give significance to our study.
In conclusion, in patients undergoing AVR for severe AS,
surgeons should inspect the LV outflow tract for possible
concomitant myectomy at AVR. Concomitant septal myec-
tomy is a simple procedure that does not increase the oper-
ative risk and gives good midterm results. However, only
longer follow-up will be able clarify the definitive useful-
ness of this associated procedure.References
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